AHR and breast cancer: In in vitro studies, AhR was demonstrated to cooperate with the Rb tumor suppressor to prevent S-phase cell cycle entry (Puga et al., 2000) while activation of AhR by the prototypical ligand TCDD inhibited the growth of MCF7 breast cancer cells (Vogel and Abel 1995).